Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Sangamo_BioSciences> ?p ?o. }
Showing items 1 to 43 of
43
with 100 items per page.
- Sangamo_BioSciences abstract "Sangamo BioSciences (NASDAQ: SGMO) is a clinical stage biopharmaceutical company involved in gene therapy that is researching ways of commercializing Zinc finger nucleases which modify a cell's DNA at an exact location thereby correcting or disrupting a specific gene.Sangamo BioSciences' lead therapy, SB-728, is a potential functional cure for HIV/AIDS. SB-728 works by removing some of the immune cells from the patient's blood that HIV attacks. The blood is sent to a lab which applies the SB-728 treatment to the patient's immune cells. The treatment removes the protein gateway on the immune cells that HIV needs to infect. The treated cells are then infused back into the patient whereby they reproduce and take over as HIV attacks and kills the non-treated cells. The treated, resistant cells thereby control the HIV infection and thus cures the patient from opportunistic infections that result from HIV. Recent published data further support the company's ongoing progress which has been described as "a major step toward immunological functional control of HIV."".
- Sangamo_BioSciences industry Biomedicine.
- Sangamo_BioSciences locationCity Richmond,_California.
- Sangamo_BioSciences locationCountry United_States.
- Sangamo_BioSciences numberOfEmployees "84".
- Sangamo_BioSciences type Public_company.
- Sangamo_BioSciences wikiPageExternalLink 66655208-sangamo-gene-tests-inspired-by-one-man-s-aids-cure.html.
- Sangamo_BioSciences wikiPageExternalLink the-face-of-the-cure.
- Sangamo_BioSciences wikiPageExternalLink new-hope-of-a-cure-for-hiv.html?pagewanted=all.
- Sangamo_BioSciences wikiPageExternalLink www.sangamo.com.
- Sangamo_BioSciences wikiPageExternalLink www.sangamo.com.
- Sangamo_BioSciences wikiPageExternalLink Targeting-DNA.
- Sangamo_BioSciences wikiPageID "36098155".
- Sangamo_BioSciences wikiPageRevisionID "599862650".
- Sangamo_BioSciences coi "June 2012".
- Sangamo_BioSciences founder "Edward O. Lanphier II".
- Sangamo_BioSciences hasPhotoCollection Sangamo_BioSciences.
- Sangamo_BioSciences homepage www.sangamo.com.
- Sangamo_BioSciences industry Biomedicine.
- Sangamo_BioSciences locationCity Richmond,_California.
- Sangamo_BioSciences locationCountry United_States.
- Sangamo_BioSciences name "Sangamo BioSciences".
- Sangamo_BioSciences numEmployees "84".
- Sangamo_BioSciences pov "June 2012".
- Sangamo_BioSciences type Public_company.
- Sangamo_BioSciences subject Category:Biotechnology_companies_of_the_United_States.
- Sangamo_BioSciences subject Category:Companies_in_the_NASDAQ_Biotechnology_Index.
- Sangamo_BioSciences type Agent.
- Sangamo_BioSciences type Company.
- Sangamo_BioSciences type Organisation.
- Sangamo_BioSciences type Organization.
- Sangamo_BioSciences type Agent.
- Sangamo_BioSciences type SocialPerson.
- Sangamo_BioSciences type Thing.
- Sangamo_BioSciences comment "Sangamo BioSciences (NASDAQ: SGMO) is a clinical stage biopharmaceutical company involved in gene therapy that is researching ways of commercializing Zinc finger nucleases which modify a cell's DNA at an exact location thereby correcting or disrupting a specific gene.Sangamo BioSciences' lead therapy, SB-728, is a potential functional cure for HIV/AIDS. SB-728 works by removing some of the immune cells from the patient's blood that HIV attacks.".
- Sangamo_BioSciences label "Sangamo BioSciences".
- Sangamo_BioSciences sameAs m.03p33br.
- Sangamo_BioSciences sameAs Q7417809.
- Sangamo_BioSciences sameAs Q7417809.
- Sangamo_BioSciences wasDerivedFrom Sangamo_BioSciences?oldid=599862650.
- Sangamo_BioSciences homepage www.sangamo.com.
- Sangamo_BioSciences isPrimaryTopicOf Sangamo_BioSciences.
- Sangamo_BioSciences name "Sangamo BioSciences".